Editorial

ALS Needs Proof, Not Just Another Biomarker

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

The Transplant Is Not the Finish Line

For Pompe Infants, Time Is the Comparator

Alzheimer’s Trials Still Measure Too Little, Too Late

Mpox Reached Guinea-Bissau. Stigma Must Not Win.

The Most Preventable Cause of Vision Loss May Still Be Smoking

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
